Focus Areas
Generating knowledge and providing greater understanding to help pharmaceutical and medical device manufacturers make better decisions
In today’s complex, competitive, and highly regulated pharmaceutical, medical device, and diagnostics industry, developers and manufacturers are regularly faced with critical decisions. But often the knowledge needed to make good clinical, market access, and safety decisions is neither readily available nor easily accessible.
RTI Health Solutions (RTI-HS) is a business unit of RTI with more than 275 experts in health economics, patient-centered outcomes research, market access, pharmacoepidemiology, biostatistics, and clinical research services. RTI-HS can assemble the right team of researchers with the deep industry experience required to answer our client's questions. Following rigorous scientific practices, we gather evidence, analyze results, increase understanding, and provide greater clarity to reveal the benefits, risks, value, and potential of our client's products.
Meet the Experts
View All Experts
Navigate to
Amy Martin
Amy Martin
Navigate to
Chris Simmons
Chris Simmons
Navigate to
Heather Danysh
Heather Danysh
Navigate to
Alicia Gilsenan
Alicia Gilsenan
Navigate to
Catherine Johannes
Catherine Johannes
Navigate to
Amy E. Chepaitis
Amy E. Chepaitis
Navigate to
William L. Herring
William L. Herring
Navigate to
Lois Holliday
Lois Holliday
Navigate to
Christine Poulos
Christine Poulos
Navigate to
Kelly Hollis
Kelly Hollis
Navigate to
Laurie Zografos
Laurie Zografos
Navigate to
Dawn Odom
Dawn Odom
Navigate to
Stephanie Earnshaw
Stephanie Earnshaw
Navigate to
Kati Copley-Merriman
Kati Copley-Merriman
Navigate to
Ari Gnanasakthy
Ari Gnanasakthy
Navigate to
Lynda Doward
Lynda Doward
Related Projects
Investigating the long-term effects of type 2 diabetes medication dapagliflozin
Postauthorization studies in the U.S. and Europe demonstrate the long-term safety of dapagliflozin
Read More about Investigating the long-term effects of type 2 diabetes medication dapagliflozin
